Cargando…

Three-Dimensional Quantitative Structure-Activity Relationships (3D-QSAR) on a Series of Piperazine-Carboxamides Fatty Acid Amide Hydrolase (FAAH) Inhibitors as a Useful Tool for the Design of New Cannabinoid Ligands

Fatty Acid Amide Hydrolase (FAAH) is one of the main enzymes responsible for endocannabinoid metabolism. Inhibition of FAAH increases endogenous levels of fatty acid ethanolamides such as anandamide (AEA) and thus consitutes an indirect strategy that can be used to modulate endocannabinoid tone. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lorca, Marcos, Valdes, Yudisladys, Chung, Hery, Romero-Parra, Javier, Pessoa-Mahana, C. David, Mella, Jaime
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566251/ https://www.ncbi.nlm.nih.gov/pubmed/31117309 http://dx.doi.org/10.3390/ijms20102510

Ejemplares similares

Design, Synthesis, Binding and Docking-Based 3D-QSAR Studies of 2-Pyridylbenzimidazoles—A New Family of High Affinity CB1 Cannabinoid Ligands
por: Mella-Raipán, Jaime A., et al.
Publicado: (2013)

3D-QSAR/CoMFA-Based Structure-Affinity/Selectivity Relationships of Aminoalkylindoles in the Cannabinoid CB1 and CB2 Receptors
por: Mella-Raipán, Jaime, et al.
Publicado: (2014)

The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition
por: Palermo, Giulia, et al.
Publicado: (2015)

The endocannabinoid hydrolase FAAH is an allosteric enzyme
por: Dainese, Enrico, et al.
Publicado: (2020)

Fatty Acid Amide Hydrolase (FAAH) Inhibition Modulates Amyloid-Beta-Induced Microglia Polarization
por: Grieco, Maddalena, et al.
Publicado: (2021)

Synthesis, Docking, 3-D-Qsar, and Biological Assays of Novel Indole Derivatives Targeting Serotonin Transporter, Dopamine D2 Receptor, and Mao-A Enzyme: In the Pursuit for Potential Multitarget Directed Ligands
por: Cerda-Cavieres, Christopher, et al.
Publicado: (2020)

2D-QSAR and 3D-QSAR/CoMSIA Studies on a Series of (R)-2-((2-(1H-Indol-2-yl)ethyl)amino)-1-Phenylethan-1-ol with Human β(3)-Adrenergic Activity
por: Apablaza, Gastón, et al.
Publicado: (2017)

N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors
por: Sunduru, Naresh, et al.
Publicado: (2017)

Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study
por: Chung, Hery, et al.
Publicado: (2019)

Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity
por: Müller, Timo D, et al.
Publicado: (2010)

Fatty Acid Amide Hydrolase (FAAH) Inhibition Plays a Key Role in Counteracting Acute Lung Injury
por: Genovese, Tiziana, et al.
Publicado: (2022)

A genetic variant of fatty acid amide hydrolase (FAAH) exacerbates hormone-mediated orexigenic feeding in mice
por: Balsevich, Georgia, et al.
Publicado: (2023)

New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists
por: Faúndez-Parraguez, Manuel, et al.
Publicado: (2021)

Author Correction: The endocannabinoid hydrolase FAAH is an allosteric enzyme
por: Dainese, Enrico, et al.
Publicado: (2020)

Motifs in Natural Products as Useful Scaffolds to Obtain Novel Benzo[d]imidazole-Based Cannabinoid Type 2 (CB2) Receptor Agonists
por: Cho, Analia Young Hwa, et al.
Publicado: (2023)

Assessment of NSAIDs as potential inhibitors of the fatty acid amide hydrolase I (FAAH-1) using three different primary fatty acid amide substrates in vitro
por: Dongdem, Julius T., et al.
Publicado: (2022)

A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)
por: Deutsch, Dale G.
Publicado: (2016)

Fatty Acid Amide Hydrolase (FAAH) Inhibitors Exert Pharmacological Effects, but Lack Antinociceptive Efficacy in Rats with Neuropathic Spinal Cord Injury Pain
por: Hama, Aldric T., et al.
Publicado: (2014)

Inhibition of Fatty Acid Amide Hydrolase (FAAH) Regulates NF-kb Pathways Reducing Bleomycin-Induced Chronic Lung Inflammation and Pulmonary Fibrosis
por: Genovese, Tiziana, et al.
Publicado: (2023)

Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review
por: Matheson, Justin, et al.
Publicado: (2021)

Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context
por: Rivera, Patricia, et al.
Publicado: (2015)

Cannabinoid Receptor 1 and Fatty Acid Amide Hydrolase Contribute to Operant Sensation Seeking in Mice
por: Helfand, Alexander I., et al.
Publicado: (2017)

Integration of enabling methods for the automated flow preparation of piperazine-2-carboxamide
por: Ingham, Richard J, et al.
Publicado: (2014)

The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study
por: Schmidt, Mark E., et al.
Publicado: (2020)

N-(4-Chlorophenyl)-4-methylpiperazine-1-carboxamide
por: Li, Yu-Feng, et al.
Publicado: (2011)

N-(4-Chlorophenyl)-4-ethylpiperazine-1-carboxamide
por: Li, Yu-Feng
Publicado: (2011)

Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors
por: Zięba, Agata, et al.
Publicado: (2021)

Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease
por: Brunetti, Leonardo, et al.
Publicado: (2019)

A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE)
por: Leuci, Rosalba, et al.
Publicado: (2022)

Inhibiting Fatty Acid Amide Hydrolase Ameliorates Enteropathy in Diabetic Mice: A Cannabinoid 1 Receptor Mediated Mechanism
por: Thakur, Vikram, et al.
Publicado: (2022)

Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors
por: Brunetti, Leonardo, et al.
Publicado: (2020)

4-Benzyl-N-methylpiperazine-1-carbothioamide
por: Alanazi, Amer M., et al.
Publicado: (2012)

A 3D-QSAR model for cannabinoid receptor (CB2) ligands derived from aligned pharmacophors
por: Günther, Robert, et al.
Publicado: (2013)

N-(4-Chlorophenyl)-4-(pyrimidin-2-yl)piperazine-1-carboxamide
por: Li, Yu-Feng
Publicado: (2011)

N-(Quinolin-8-yl)quinoline-2-carboxamide
por: Li, Yanfeng, et al.
Publicado: (2012)

N-(Quinolin-8-yl)ferrocene-1-carboxamide
por: Li, Xia, et al.
Publicado: (2011)

Crystal structure of benzo[h]quinoline-3-carboxamide
por: Grathwol, Christoph W., et al.
Publicado: (2019)

Pharmacological characterization of a novel, potent, selective, and orally active fatty acid amide hydrolase inhibitor, PKM‐833 [(R)‐N‐(pyridazin‐3‐yl)‐4‐(7‐(trifluoromethyl)chroman‐4‐yl)piperazine‐1‐carboxamide] in rats: Potential for the treatment of inflammatory pain
por: Endo, Toshiya, et al.
Publicado: (2020)

QSAR Model for Predicting the Cannabinoid Receptor 1 Binding Affinity and Dependence Potential of Synthetic Cannabinoids
por: Lee, Wonyoung, et al.
Publicado: (2020)

FAAH inhibitors in the limelight, but regrettably
por: Mallet, Christophe, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ug1rf9u0unfbgoijcu55aoedst